#MSBlog : March natalizumab PML update; 343 confirmed cases with a 23% mortality rate on a denominator of more than 112,000 treated MSers. ...
#MSBlog : March natalizumab PML update; 343 confirmed cases with a 23% mortality rate on a denominator of more than 112,000 treated MSers. ...
#MSBlog : February 2013 update: 331 natalizumab-related cases of PML; 23% mortality. "As of the 5th February 2013 there have been 331 c...
"I read an interesting article on my way to work this morning; for those of you who don't know I commute by Tube or the London Und...
#MSBlog : As of the 2 January 2013 there have been 323 confirmed cases of natalizumab-associated PML. "If you are on Natalizumab we wou...
#MSBlog : If you are natalizumab, or Tysabri, and are worried about PML this post if for you! Epub : Lindå H, von Heijne A. Presymptomatic d...
#MSBlog : Children with MS respond very well to Natalizumab. Good news for anxious parents! Epub : Ghezzi et al. Nataluzimab in pediatric m...
NEWS RELEASE : Biogen-Idec will terminate its collaboration with Elan, the Dublin-based drug maker that developed Natalizumab, and buy Elan’...
Yahoo Finance. Biogen Idec and Elan submit applications for first-Line Use of natalizumab in anti-JCV antibody negative patients with MS. 16...
#MSBlog : Natalizumab starts working within 2-3 months. Therefore any relapse destined to happen in the first 2-3months will probably occur...
#MSBlog: How soon after stopping natalizumab (Tysabri) do you start fingolimod (Gilenya) ? Epub : Havla et al. Fingolimod reduces recurrenc...
"As of the 30th November there have been 312 confirmed cases of Natalizumab-related PML! Slide 5, 6 and 19 give you the latest risk str...